AVPR2 and Hyponatremia: As such, it is tempting to anticipate that both such direct inhibition of multiple K+ currents and blockade of vasopressin V2 receptor by this drug or other structurally similar non-peptide compounds produce beneficial effects on patients with hyponatremia or syndrome of inappropriate antidiuretic hormone secretion.